|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2010-4-21
|
|
pubmed:abstractText |
Raltegravir and maraviroc represent new, important resources for HIV-infected patients with intolerance or resistance to other antiretroviral agents. The safety and efficacy of both drugs have been investigated, but there is no information on possible pharmacokinetic interactions between these 2 drugs in clinical practice.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1542-6270
|
|
pubmed:author |
pubmed-author:BaroncelliSilviaS,
pubmed-author:CicaliniStefaniaS,
pubmed-author:CusatoMariaM,
pubmed-author:FloridiaMarcoM,
pubmed-author:FrancisciDanielaD,
pubmed-author:GalluzzoClementinaC,
pubmed-author:ISS-NIA Group,
pubmed-author:LadisaNicolettaN,
pubmed-author:PreziosiRobertaR,
pubmed-author:RegazziMarioM,
pubmed-author:TommasiChiaraC,
pubmed-author:VillaniPaolaP,
pubmed-author:VulloVincenzoV,
pubmed-author:WeimerLiliana ELE
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
44
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
838-43
|
|
pubmed:meshHeading |
pubmed-meshheading:20371753-Adult,
pubmed-meshheading:20371753-Aged,
pubmed-meshheading:20371753-Anti-HIV Agents,
pubmed-meshheading:20371753-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:20371753-Cohort Studies,
pubmed-meshheading:20371753-Cyclohexanes,
pubmed-meshheading:20371753-Drug Administration Schedule,
pubmed-meshheading:20371753-Drug Interactions,
pubmed-meshheading:20371753-HIV Infections,
pubmed-meshheading:20371753-Humans,
pubmed-meshheading:20371753-Male,
pubmed-meshheading:20371753-Middle Aged,
pubmed-meshheading:20371753-Pyrrolidinones,
pubmed-meshheading:20371753-Salvage Therapy,
pubmed-meshheading:20371753-Triazoles,
pubmed-meshheading:20371753-Young Adult
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Raltegravir plasma concentrations in treatment-experienced patients receiving salvage regimens based on raltegravir with and without maraviroc coadministration.
|
|
pubmed:affiliation |
Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanità, Rome, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study
|
